Phase 3 Clinical trial of Oxford COVID-19 Vaccine Starts in Brazil
Researchers from the Oxford University have began the phase 3 clinical trial of their COVID 19 vaccine in Brazil, the University announced yesterday(29th June 2020). On June 2nd the Brazilian Health Regulatory Agency (ANVISA) granted their permission to carry out Vaccine trials in Brazil, which is one of the hardest hit countries by the ongoing COVID 19 pandemic.
Phase 3 Clinical trial of Oxford COVID-19 Vaccine Starts in Brazil Read More